Clinical Trials
33 trialsctDNA
Institute of Oncology Ljubljana
ENZYMELA
Assistance Publique - Hôpitaux de Paris
MELANFα
Institut Claudius Regaud
AMMAM
Centre Hospitalier Universitaire de Nice
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
University of California, San Francisco
IMMUNONIVO
Hospices Civils de Lyon
PAIR
Hospices Civils de Lyon
NeoEpitope
Institut Curie
Pan-tumor MRD Study
Paradigm Health
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
TIL
The Netherlands Cancer Institute
VerSiLiB
Regina Elena Cancer Institute
COLEMAN
Hospices Civils de Lyon
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Vanderbilt-Ingram Cancer Center
OpACIN-neo
The Netherlands Cancer Institute
OPTIMEL
Institut de Cancérologie de Lorraine
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Assistance Publique Hopitaux De Marseille
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
Aalborg University Hospital
Ipi4
Oslo University Hospital
REPOSIT
Netherlands Working Group on Immunotherapy of Oncology
NAKIMEL
Assistance Publique - Hôpitaux de Paris
Sample Collection From Melanoma Patients
M.D. Anderson Cancer Center
Onco-PDL1s/B2M
University Hospital, Clermont-Ferrand
Circulating Tumor Material in Colorectal Cancer and Melanoma
Abramson Cancer Center at Penn Medicine
ADOPT
University of Dundee
ONCOPRO
Hospices Civils de Lyon
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
CTC
Comprehensive Cancer Centers of Nevada
MSN
Gustave Roussy, Cancer Campus, Grand Paris
Differential Risks for Melanoma: p16 and DNA Repair
Memorial Sloan Kettering Cancer Center